178 related articles for article (PubMed ID: 15479493)
1. Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.
Gilligan T; Manola J; Sartor O; Weinrich SP; Moul JW; Kantoff PW
Clin Prostate Cancer; 2004 Sep; 3(2):98-103. PubMed ID: 15479493
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
3. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
4. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
Bennett CL; Price DK; Kim S; Liu D; Jovanovic BD; Nathan D; Johnson ME; Montgomery JS; Cude K; Brockbank JC; Sartor O; Figg WD
J Clin Oncol; 2002 Sep; 20(17):3599-604. PubMed ID: 12202660
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset.
Hardy DO; Scher HI; Bogenreider T; Sabbatini P; Zhang ZF; Nanus DM; Catterall JF
J Clin Endocrinol Metab; 1996 Dec; 81(12):4400-5. PubMed ID: 8954049
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
7. The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancer.
Mir K; Edwards J; Paterson PJ; Hehir M; Underwood MA; Bartlett JM
BJU Int; 2002 Oct; 90(6):573-8. PubMed ID: 12230620
[TBL] [Abstract][Full Text] [Related]
8. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
Nam RK; Elhaji Y; Krahn MD; Hakimi J; Ho M; Chu W; Sweet J; Trachtenberg J; Jewett MA; Narod SA
J Urol; 2000 Aug; 164(2):567-72. PubMed ID: 10893645
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.
Santos ML; Sarkis AS; Nishimoto IN; Nagai MA
Cancer Detect Prev; 2003; 27(5):321-6. PubMed ID: 14585317
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
[TBL] [Abstract][Full Text] [Related]
11. GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men.
Vijayalakshmi K; Thangaraj K; Rajender S; Vettriselvi V; Venkatesan P; Shroff S; Vishwanathan KN; Paul SFD
J Hum Genet; 2006; 51(11):998-1005. PubMed ID: 16969583
[TBL] [Abstract][Full Text] [Related]
12. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.
Giovannucci E; Stampfer MJ; Krithivas K; Brown M; Dahl D; Brufsky A; Talcott J; Hennekens CH; Kantoff PW
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3320-3. PubMed ID: 9096391
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer.
Sartor O; Zheng Q; Eastham JA
Urology; 1999 Feb; 53(2):378-80. PubMed ID: 9933058
[TBL] [Abstract][Full Text] [Related]
15. CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients: potential predictor of prognosis after endocrine therapy.
Suzuki H; Akakura K; Komiya A; Ueda T; Imamoto T; Furuya Y; Ichikawa T; Watanabe M; Shiraishi T; Ito H
Prostate; 2002 May; 51(3):219-24. PubMed ID: 11967956
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor CAG polymorphism and prostate cancer risk.
Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
[TBL] [Abstract][Full Text] [Related]
18. A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects.
Beilin J; Harewood L; Frydenberg M; Mameghan H; Martyres RF; Farish SJ; Yue C; Deam DR; Byron KA; Zajac JD
Cancer; 2001 Aug; 92(4):941-9. PubMed ID: 11550169
[TBL] [Abstract][Full Text] [Related]
19. Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians.
Akinloye O; Gromoll J; Simoni M
Br J Biomed Sci; 2011; 68(3):138-42. PubMed ID: 21950206
[TBL] [Abstract][Full Text] [Related]
20. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]